2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

January, Craig T., Wann, L. Samuel, Alpert, Joseph S., Calkins, Hugh, Cigarroa, Joaquin E., Cleveland, Joseph C., Conti, Jamie B., Ellinor, Patrick T. +8 more·2014·Circulation
DOI 10.1161/cir.0000000000000040

Cites (244)

Items 201–244 of 244

  1. Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: An analysis of pooled trials
    Eduardo A Moreyra, Robert S. Finkelhor, Randall D. Cebul · 1995 · American Heart Journal
  2. Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation
    Edward L.C. Pritchett, Richard L. Page, Mark D. Carlson, K. P. Undesser, Gerald Fava · 2003 · The American Journal of Cardiology
  3. Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter
    Sheila A. Roberts, Claro Diaz, Paul E. Nolan, David M. Salerno, J. Stephan Stapczynski, Arthur S. Zbrozek, Elsbeth G. Ritz, Jerry L. Bauman, Peter H. Vlasses · 1993 · The American Journal of Cardiology
  4. Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy
    Fethi Kılıçaslan, Atul Verma, Eduardo Saad, Sakis Themistoclakis, Aldo Bonso, Antonio Raviele, Hüseyin Bozbaş, Michelle Williams Andrews, Salwa Beheiry, Steven C. Hao et al. · 2006 · Heart Rhythm
  5. Efficacy of Ibutilide for Termination of Atrial Fibrillation and Flutter
    Kenneth A. Ellenbogen, Henry F. Clemo, Bruce Sheldon Stambler, Mark A. Wood, James T. VanderLugt · 1996 · The American Journal of Cardiology
  6. Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial
    John J.V. McMurray, James B. Young, Mark E. Dunlap, Christopher Bull Granger, James W. Hainer, Eric L. Michelson, Steven Earle, Bertil Olofsson, Jan Östergren, Salim Yusuf et al. · 2006 · American Heart Journal
  7. Effectiveness of Amiodarone for Conversion of Atrial Fibrillation to Sinus Rhythm: A Meta-analysis
    Letelier, Luz M., Udol, Kamol, Ena, Javier, Weaver, Bruce, Guyatt, Gordon H. · 2003 · Archives of Internal Medicine
  8. Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: A multicenter double-blind clinical trial
    Jonathan Abrams, John Allen, Douglas Allin et al. · 1985 · American Heart Journal
  9. Dabigatran Etexilate in Atrial Fibrillation Patients With Severe Renal Impairment: Dose Identification Using Pharmacokinetic Modeling and Simulation
    Thorsten Lehr, Sebastian Haertter, Karl‐Heinz Liesenfeld, Alexander Staab, Andreas Clemens, Paul A. Reilly, Jeffrey E. Friedman · 2011 · The Journal of Clinical Pharmacology
  10. Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation
    Siu, Chung-Wah, Lau, Chu-Pak, Lee, Wai-Luen, Lam, Kwok-Fai, Tse, Hung-Fat · 2009 · Critical Care Medicine
  11. Effects of Atenolol, Verapamil, and Xamoterol on Heart Rate and Exercise Tolerance in Digitalised Patients with Chronic Atrial Fibrillation
    R V Lewis, John J.V. McMurray, DG McDevitt · 1989 · Journal of Cardiovascular Pharmacology
  12. Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation
    Khan, Ijaz A., Mehta, Nirav J., Gowda, Ramesh M. · 2003 · International Journal of Cardiology
  13. Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review
    Ioanna C. Koniari, Efstratios E. Apostolakis, Christina Rogkakou, Nikolaos G. Baikoussis, Dimitrios Dougenis · 2010 · Journal of Cardiothoracic Surgery
  14. Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy
    Gaita, Fiorenzo, Di Donna, Paolo, Olivotto, Iacopo, Scaglione, Marco, Ferrero, Ivana, Montefusco, Antonio, Caponi, Domenico, Conte, Maria Rosa, Nistri, Stefano, Cecchi, Franco · 2007 · The American Journal of Cardiology
  15. Enhanced Detection Criteria in Implantable Cardioverter-Defibrillators to Avoid Inappropriate Therapy
    Anselm Schaumann, Friederike von zur Mühlen, Bernd‐Dieter Gonska · 1996 · The American Journal of Cardiology
  16. Clinical Pharmacology Basis of Deriving Dosing Recommendations for Dabigatran in Patients With Severe Renal Impairment
    Sudharshan Hariharan, Rajanikanth Madabushi · 2011 · The Journal of Clinical Pharmacology
  17. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation
    Francesco Bellandi, Ignazio Simonetti, Mario Leoncini, Fabio Frascarelli, Tiziana Giovannini, Mauro Maioli, Roberto Piero Dabizzi · 2001 · The American Journal of Cardiology
  18. Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials
    Carlo Bonanno, Mariemma Paccanaro, Luigi La Vecchia, RENATO OMETTO, Alessandro Fontanelli · 2010 · Journal of Cardiovascular Medicine
  19. A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation
    Kevin Stephen Channer · 2004 · European Heart Journal
  20. Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation
    Greg C. Flaker, Michael D. Ezekowitz, Salim Yusuf, Lars C. Wallentin, Herbert Noack, Martina Brueckmann, Paul A. Reilly, Stefan Hans Hohnloser, Stuart J. Connolly · 2012 · Journal of the American College of Cardiology
  21. Efficacy of Amiodarone for the Termination of Chronic Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: A Prospective, Multicenter, Randomized, Controlled, Double Blind Trial
    Jorge Galperín, Marcelo Victor Elizari, Pablo Ambrosio Chiale, Remberto Torres Molina, R Ledesma, Angel O. Scapín, Manuel Vaacutezquez Blanco · 2001 · Journal of Cardiovascular Pharmacology and Therapeutics
  22. Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise
    Jonathan S. Steinberg, Richard J. Katz, George B. Bren, Leslie A. Buff, P.Jacob Varghese · 1987 · Journal of the American College of Cardiology
  23. Correction
    2014 · Journal of the American College of Cardiology
  24. Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation
    Boriani, Giuseppe, Biffi, Mauro, Frabetti, Lorenzo, Azzolini, Umberto, Sabbatani, Paolo, Bronzetti, Gabriele, Capucci, Alessandro, Magnani, Bruno · 1996 · American Heart Journal
  25. Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation
    Jens Cosedis Nielsen, Arne Cyron Johannessen, Pekka M. J. Raatikainen, Gerhard Hindricks, Håkan Walfridsson, Ole Kongstad, Steen Michael Pehrson, Anders Englund, Juha E.K. Hartikainen, Leif Spange Mortensen et al. · 2014 · Survey of Anesthesiology
  26. Pharmacological rate control of atrial fibrillation
    Tamariz, Leonardo J, Bass, Eric B · 2004 · Cardiology Clinics
  27. Pharmacologic Prophylaxis of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Beyond β‐Blockers
    Estella M. Davis, Kathleen A. Packard, Daniel E. Hilleman · 2010 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  28. Work related physical activity and risk of a hospital discharge diagnosis of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study
    Lars Frost, Poul Frost, Poul Frølund Vestergaard · 2004 · Occupational and Environmental Medicine
  29. Correction
    2014 · Journal of the American College of Cardiology
  30. Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation
    Sharis M. Simonian, Shahram Lotfipour, Christopher Wall, Mark I. Langdorf · 2010 · Internal and Emergency Medicine
  31. Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) Trial
    Sana M. Al‐Khatib, Gail E. Hafley, Robert A. Harrington, Michael J. Mack, Thomas Bruce Ferguson, Eric David Peterson, Robert M. Califf, Nicholas Thomas Kouchoukos, John Hunter Alexander · 2009 · American Heart Journal
  32. Effect of High Doses of Magnesium on Converting Ibutilide to a Safe and More Effective Agent
    Sotirios P. Patsilinakos, Apostolos H. Christou, Nikolaos V. Kafkas, Nikolaos I Nikolaou, Dionysios G. Antonatos, Spyridon Katsanos, STAVROS G. SPANODIMOS, Dimitrios Babalis · 2010 · The American Journal of Cardiology
  33. New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation
    Yousif Ahmad, Gregory Y.H. Lip, Stavros Z. Apostolakis · 2012 · Expert Review of Cardiovascular Therapy
  34. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation
    Jonathan Shepherd, John J. Jones, Geoff K Frampton · 2008 · Health Technology Assessment
  35. Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No Previous History of Stroke or Transient Ischemic Attacks
    Maria I. Aguilar, Robert G. Hart · 2005 · Stroke
  36. Is Discharge to Home After Emergency Department Cardioversion Safe for the Treatment of Recent-Onset Atrial Fibrillation?
    Kiera von Besser, Angela M. Mills · 2011 · Annals of Emergency Medicine
  37. Prevention of stroke in patients with atrial fibrillation: current strategies and future directions
    Stefan Hans Hohnloser, Gábor Zoltán Duray, Usman Baber, Jonathan L. Halperin · 2008 · European Heart Journal Supplements
  38. Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion
    Abdullah Doğan, Oktay Ergene, Cem Nazlı, Ozan Kınay, Ahmet Altınbaş, Yesim Ucarci, Ülkü Ergene, Mehmet Özaydın, Ömer Gedikli · 2004 · Acta Cardiologica
  39. Initiating and Maintaining Patients on Warfarin Anticoagulation: The Importance of Monitoring
    Michael D. Ezekowitz, Kenneth E. James, Martha J. Radford · 1999 · Journal of Cardiovascular Pharmacology and Therapeutics
  40. Pharmacological Management of Atrial Fibrillation following Cardiac Surgery
    Daniel E. Hilleman, Claire B. Hunter, Syed M. Mohiuddin, Stephanie R. Maciejewski · 2005 · American Journal of Cardiovascular Drugs
  41. Precipitation of Ventricular Fibrillation by Intravenous Diltiazem and Metoprolol in a Young Patient with Occult Wolff‐Parkinson‐White Syndrome
    Robert J. Kim, Barbara R. Gerling, Alan Kono, MARK L. GREENBERG · 2008 · Pacing and Clinical Electrophysiology
  42. Postoperative Treatment of Carvedilol Following Low Dose Landiolol has Preventive Effect for Atrial Fibrillation after Coronary Artery Bypass Grafting
    Ichiro Yoshioka, Masahiro Sakurai, Asako Namai · 2009 · The Thoracic and Cardiovascular Surgeon
  43. 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons Endorsed by the American Association for Clinical Chemistry WRITING COMMITTEE MEMBERS*
    Ezra A. Amsterdam, NANETTE KASS WENGER, Ralph G. Brindis, Donald E. Casey, Théodore G. Ganiats, David R. Holmes, Allan S. Jaffe, Hani M. Jneid, Rosemary F. Kelly, Michael Christopher Kontos et al. · 2014
  44. Hyperthyroidism and Risk of Atrial Fibrillation or Flutter: A Population-Based Study
    Frost, Lars, Vestergaard, Peter, Mosekilde, Leif · 2004 · Archives of Internal Medicine